MP

Manikandan Periyanahalli Madha Chetty

Director Director DIN 08253782
DIN 08253782 First appointment Oct 2018 Primary industry Chemicals
Unlock full profile Investments Β· shareholding Β· contact details
Past companies 1 historical roles
Total affiliations 1 Since Oct 2018
Shareholding value β€’β€’β€’β€’ Premium profile

About Manikandan Periyanahalli Madha Chetty

Data last updated:

Manikandan Periyanahalli Madha Chetty was a Director at Henley Pharmaceuticals Private Limited (2018–2020). The company operates in Chemicals.

DIN 08253782
Primary Designation Director
Industry Chemicals
First Appointment 10 Oct 2018

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director10 Oct 20182018₹1.09 Cr (FY 2022)Active

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Henley Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Manikandan Periyanahalli Madha Chetty

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Manikandan Periyanahalli Madha Chetty

Manikandan Periyanahalli Madha Chetty was first appointed on 10 Oct 2018 as Director at Henley Pharmaceuticals Private Limited.

Manikandan Periyanahalli Madha Chetty held 1 earlier board appointment: Henley Pharmaceuticals Private Limited (Director, 10 Oct 2018 to 12 Aug 2020).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available